Announcement

Collapse
No announcement yet.

Netherlands - H1N1 - Mutations in the hemagglutinin protein

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Netherlands - H1N1 - Mutations in the hemagglutinin protein

    machinetranslated, edited a little

    Mutations in the hemagglutinin protein.

    From Norway viruses were first reported that had a mutation in
    the HA gene
    include involving a substitution at amino acid position 222 of the protein.

    The mutation was detected in patient material from two fatal cases of
    pandemic (H1N1)
    2009-virus infections. A third case involved a patient with pneumonia.

    The relevant D222G
    (aspartic acid to glycine) substitution may affect the receptor specificity
    as described
    for the 1918 Spanish influenza virus (Stevens et al J. Mol. Biol. 355:1143-55, 2006)
    where the mutation
    correlates with a shift in receptor specificity of α (2-6)-linked
    siaalzuren to
    α (2-3)-linked siaalzuren. The latter receptors are strongly represented
    in the lower
    airways, which correlated with the development of a more severe pandemic (H1N1) 2009 --
    viral infections
    could explain.

    In the Netherlands, this mutation was proved once and in the Ukraine
    four times with fatal cases. The mutation is also found elsewhere, but unknown
    is whether there
    there was severe disease.

    In addition,in the Netherlands and elsewhere,

    two other mutations were observed

    in the same position in the HA gene,

    namely D222E (aspartic to glutamic acid)

    and D222N (aspartic acid to asparagine) substitutions.


    However, a correlation with the severity of the infection
    and these mutations is not clear,

    because it is frequently found even in less severe cases.



    source:

    INFLUENZA SURVEILLANCE-NEWSLETTER 2009/10

    Published by:

    National Influenza Center (NIC): Rotterdam (Erasmus MC), Bilthoven (RIVM),

    Dutch Institute for Health Services Research (NIVEL),

    Health Care Inspectorate (IGZ).

    27.11 --
    "Addressing chronic disease is an issue of human rights that must be our call to arms"
    Richard Horton, Editor-in-Chief The Lancet
Working...
X